Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections
- 30 June 2004
- journal article
- Published by Elsevier in Journal of Hospital Infection
- Vol. 57 (2) , 112-118
- https://doi.org/10.1016/j.jhin.2004.03.021
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variationNature, 2002
- Clonal Spread of Imipenem-ResistantPseudomonas aeruginosain the Intensive Care Unit of a Turkish HospitalJournal of Chemotherapy, 2001
- Epidemiology of Ciprofloxacin-Resistant Pseudomonas aeruginosa in a Veterans Affairs HospitalClinical Journal of Sport Medicine, 2000
- Emergence of Antibiotic-Resistant Pseudomonas aeruginosa : Comparison of Risks Associated with Different Antipseudomonal AgentsAntimicrobial Agents and Chemotherapy, 1999
- Health and Economic Outcomes of Antibiotic Resistance in Pseudomonas aeruginosaArchives of internal medicine (1960), 1999
- Epidemiology and Clinical Outcomes of Patients with Multiresistant Pseudomonas aeruginosaClinical Infectious Diseases, 1999
- Imipenem‐ResistantPseudomonas aeruginosa: Risk Factors and Antibiotic Susceptibility PatternsClinical Infectious Diseases, 1997
- National Nosocomial Infections Surveillance (NNIS) Report, data summary from October 1986–April 1996, issued May 1996American Journal of Infection Control, 1996
- CDC definitions for nosocomial infections, 1988American Journal of Infection Control, 1988